EmCare’s parent company receives a “sell” rating from Zacks: 3 points

Envision Healthcare, the parent company of EmCare, received a “sell” rating for the short term from Zacks, according to an American Trade Journal report.

Advertisement

Here are three points:

1. Fourteen analysts have given Envision Healthcare stock a near short term price target of $38.29

2. The 52-week high of the share price is $45.95 and the 52-week low is $20.33.

3. The company has a market cap of $4.77 billion.

More articles on anesthesia:
National Health Council names ASA CEO Paul Pomerantz treasurer: 3 points
Weill Cornell Medical College names Dr. Sheida Tabaie the anesthesia department’s Global Health Fellow: 4 points
A kidney donor death highlights the dangers of anesthesia — 4 things to know

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.